FDA Drug Recalls

18,003 recalls, newest first

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 16714-089-01 D-1062-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 6714-088-01 D-1061-2022

Apr 13, 2022 Class II · Moderate risk

Medroxyprogesterone acetate injectable suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 16714-981-01 D-1060-2022

Apr 13, 2022 Class II · Moderate risk

Sulfamethoxazole and Trimethoprim Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-2725-61 D-1059-2022

Apr 13, 2022 Class II · Moderate risk

Sodium Bicarbonate Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0536-1047-10 D-1058-2022

Apr 13, 2022 Class II · Moderate risk

Promethazine HCl Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6461-61 D-1057-2022

Apr 13, 2022 Class II · Moderate risk

Metronidazole tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-1453-61 D-1056-2022

Apr 13, 2022 Class II · Moderate risk

Ibuprofen Tablets USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-5853-61 D-1055-2022

Apr 13, 2022 Class II · Moderate risk

Doxycycline Hyclate Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-0430-06 D-1054-2022

Apr 13, 2022 Class II · Moderate risk

Xylocaine + Epinephrine

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-483-27 D-1053-2022

Apr 13, 2022 Class II · Moderate risk

Xylocaine + Epinephrine

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-482-27 D-1052-2022

Apr 13, 2022 Class II · Moderate risk

Glucagon Emergency Kit for Low Blood Sugar

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0002-8031-01 D-1051-2022

Apr 13, 2022 Class II · Moderate risk

Xylocaine - MPF

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-0487-31 D-1050-2022

Apr 13, 2022 Class II · Moderate risk

Nitrostat (Nitroglycerin Sublingual Tablets, USP)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0071-0418-13 D-1049-2022

Apr 13, 2022 Class II · Moderate risk

Metronidazole Vaginal Gel USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-7077-87 D-1048-2022

Apr 13, 2022 Class II · Moderate risk

Lidocaine and Prilocaine Cream

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0357-56 D-1047-2022

Apr 13, 2022 Class II · Moderate risk

HydrOXYzine Pamoate Capsules

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0185-0615-01 D-1046-2022

Apr 13, 2022 Class II · Moderate risk

Hydrocortisone Ointment USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0146-30 D-1045-2022

Apr 13, 2022 Class II · Moderate risk

Ciprofloxacin Ophthalmic Solution 0.3%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-656-05 D-1044-2022

Apr 13, 2022 Class II · Moderate risk

Lidocaine Patch 5%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0603-1880-16 D-1043-2022

Apr 13, 2022 Class II · Moderate risk

Olanzapine Orally Disintegrating Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-321-55 D-1042-2022

Apr 13, 2022 Class II · Moderate risk

ClomiPHENE Citrate Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-701-55 D-1041-2022

Apr 13, 2022 Class II · Moderate risk

Ipratropium Bromide Inhalation Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-9801-25 D-1040-2022

Apr 13, 2022 Class II · Moderate risk

Naltrexone Hydrochloride Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0406-1170-03 D-1039-2022

Apr 13, 2022 Class II · Moderate risk

Glucagen (glucagon)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0597-0053-45 D-1038-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061